Accuracy of Diagnostic Investigations in Monitoring Hepatitis B Virus Infection: Strengths, Limitations, and Emerging Biomarkers
International Journal of Molecular Sciences · 07.03.2026 · 27 (5) · 2464
DOI: 10.3390/ijms27052464 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.03.2026. Verfasst von Laura Iulia Bozomitu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania. Hauptthemen laut MEDLINE: Biomarkers, Hepatitis B virus, Hepatitis B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In October 2020, the International Coalition to Eliminate Hepatitis B Virus (ICE-HBV) updated the biomarker framework; they underscored major advances in the understanding of viral and immunologic markers, yet highlighted persistent gaps in their clinical integration. This is particularly the case in low- and middle-income regions, where HBV remains a substantial public health problem, including in the pediatric population. To synthesize contemporary evidence, a structured literature search was performed across PubMed/MEDLINE, Scopus, and Web of Science. Classical biomarkers—including HBeAg, HBV DNA, and quantitative HBsAg—remain central for disease staging and therapeutic monitoring, while emerging markers enhance precision in risk stratification: HBcrAg, which correlates strongly with intrahepatic cccDNA activity and virological rebound after NA discontinuation; serum HBV RNA, which offers additional insight into transcriptional activity, which is particularly relevant for RNA-targeted therapies; and quantitative anti-HBc (qAnti-HBc), which reflects stronger humoral imprinting and more competent HBV-specific immune memory, and is consistently associated with fewer ALT flares and reduced virological rebound at end of treatment. Despite these advances, assay standardization, genotype-related variability, and limited pediatric data constrain broad clinical application. Integrating classical and emerging biomarkers into personalized therapeutic algorithms offers substantial potential for refining treatment decisions, predicting post-treatment outcomes, and advancing HBV elimination strategies in diverse clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
- Pediatrics-"Sf. Maria" Clinical Emergency Children Hospital, 700309 Iasi, Romania.
ORCID-Profile: Ancuta Lupu, Vasile Valeriu Lupu, Nicoleta Gimiga, Dana Teodora Anton Paduraru, Carmen Anton, Emil Anton, Anca Adam-Raileanu, Lorenza Forna
Zitieren
APA
Bozomitu, L. I., Lupu, A., Lupu, V. V., Gimiga, N., Anton Paduraru, D. T., Mîndru, D. E., Mihai, M., Anton, C., Anton, E., Mitrea, M., Adam-Raileanu, A., & Forna, L. (2026). Accuracy of Diagnostic Investigations in Monitoring Hepatitis B Virus Infection: Strengths, Limitations, and Emerging Biomarkers. International Journal of Molecular Sciences, 27(5), 2464. https://doi.org/10.3390/ijms27052464
Vancouver
Bozomitu LI, Lupu A, Lupu VV, Gimiga N, Anton Paduraru DT, Mîndru DE, et al. Accuracy of Diagnostic Investigations in Monitoring Hepatitis B Virus Infection: Strengths, Limitations, and Emerging Biomarkers. International Journal of Molecular Sciences. 2026;27(5):2464. doi:10.3390/ijms27052464
BibTeX
@article{Bozomitu2026,
author = {Bozomitu, Laura Iulia and Lupu, Ancuta and Lupu, Vasile Valeriu and Gimiga, Nicoleta and Anton Paduraru, Dana Teodora and Mîndru, Dana Elena and Mihai, Mihaela and Anton, Carmen and Anton, Emil and Mitrea, Mihaela and Adam-Raileanu, Anca and Forna, Lorenza},
title = {Accuracy of Diagnostic Investigations in Monitoring Hepatitis B Virus Infection: Strengths, Limitations, and Emerging Biomarkers},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {5},
pages = {2464},
doi = {10.3390/ijms27052464}
}
EUVIMED